---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-004395"
form_type: "8-K"
ticker: "IDYA"
cik: "0001676725"
company_name: "IDEAYA Biosciences, Inc."
filed_at: "2024-01-16T23:59:59+00:00"
generated_at: "2026-06-06T23:17:53.859000+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# IDEAYA Biosciences sells 1.56M shares for $57M net under ATM, exhausting $250M facility

## Summary
- Sold 1,561,735 shares at ~$37.60/share, net proceeds ~$57.0M under June 2023 ATM with Jefferies.
- As of Jan 15, 2024, no shares remain available under the ATM facility (originally up to $250M).
- Company filed automatic shelf registration S-3 in June 2023; ATM program now fully utilized.

## SEC filing metadata
- accession: 0000950170-24-004395
- form_type: 8-K
- ticker: IDYA
- cik: 0001676725
- company_name: IDEAYA Biosciences, Inc.
- filed_at: 2024-01-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1676725/000095017024004395/0000950170-24-004395-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1676725/000095017024004395/idya-20240112.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-004395
- JSON: https://secwatch.observer/filing/0000950170-24-004395.json
- Plain text: https://secwatch.observer/filing/0000950170-24-004395.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.